Studies with experimental models of dysmyelination and demyelination h
ave shown that rodent Schwann cells including a Schwann cell line, tra
nsplanted in the central nervous system compete with host oligodendroc
ytes to remyelinate denuded central axons of the spinel cord. The myel
in Produced by transplanted SC around these central nervous system axo
ns is structurally normal end restores, secure nerve conduction. In th
e presence of a favorable substrate, transplanted Schwann cells migrat
e over considerable distances (several mm) and ore recruited by a demy
elinated lesion which they will partially repair. Thus Schwann cells,
which con also support oxonol growth, may be instrumental in central n
ervous system repair In addition, the possibility of obtaining large q
uantities of human end non-human primate Schwann cells, makes it possi
ble to consider autologous Schwann cell transplantation as a potential
therapy for demyelinating or traumatic diseases. The various differen
ces which may exist between rodents and humans, however, require furth
er investigation of this possibility in a non-human primate model of d
emyelination. These experiments should Provide not only insights on th
e potential of autologous transplantation in primates but also a bette
r understanding of the process of central remyelination.